ABVC BioPharma, Inc. Security Deposit Liability
ABVC BioPharma, Inc. (ABVC) had Security Deposit Liability of $31.17 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:SecurityDepositLiability · last filed 2026-08-12
- 2026-06-30: Security Deposit Liability $31.17K.
- 2025-09-30: Security Deposit Liability $12.00K.
- 2025-06-30: Security Deposit Liability $41.68K.
- 2025-03-31: Security Deposit Liability $21.68K.
| Period end | Security Deposit Liability |
|---|---|
| 2026-06-30 | $31.17K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $12.00K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $41.68K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $21.68K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $21.68K 10-Q/A · filed 2026-03-03 |
| 2024-09-30 | $25.68K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $27.68K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $21.68K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $21.68K 10-K · filed 2025-04-15 |
| 2023-09-30 | $5.68K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $5.68K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.48K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.98K 10-K · filed 2024-03-13 |
| 2022-09-30 | $12.88K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $11.98K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $7.98K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $10.58K 10-K · filed 2023-03-31 |
| 2021-09-30 | $9.88K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $17.18K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $11.08K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $19.28K 10-K · filed 2022-03-31 |
| 2020-09-30 | $20.03K 10-Q · filed 2020-11-17 |
| 2020-06-30 | $4.68K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.88K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $2.88K 10-K · filed 2021-03-16 |
| 2019-09-30 | $2.88K 10-Q · filed 2019-11-18 |
| 2019-06-30 | $2.88K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.88K 10-Q · filed 2019-05-28 |